Literature DB >> 11426979

Vascular endothelial growth factor C gene expression is closely related to invasion phenotype in gynecological tumor cells.

M Ueda1, Y Terai, K Kumagai, K Ueki, H Yamaguchi, D Akise, M Ueki.   

Abstract

OBJECTIVE: The correlation between the gene expression of various angiogenic factors and in vitro invasive activity in 16 human gynecological cancer cell lines was investigated.
METHODS: Semiquantitative reverse transcription polymerase chain reaction analysis was performed to investigate the mRNA expression levels of vascular endothelial growth factors (VEGF-A, -B, -C, and -D), basic fibroblast growth factor (bFGF), and matrix metalloproteinase (MMP)-2 with beta-actin coamplified as an internal standard. Tumor cell migration along a gradient of substratum-bound fibronectin and invasion into reconstituted basement membrane were evaluated by haptotactic migration and invasion assay.
RESULTS: Expression of VEGF-A mRNA was detected in all 16 cell lines, whereas the relative expression levels of other VEGF family members and bFGF, differed markedly among the cell lines. There was a statistical correlation between VEGF-C gene expression and the number of cells that migrated and invaded (P < 0.01). However, expression of mRNAs of other angiogenic factors did not correlate with motility and invasive activity of the cells. Moreover, there was a close correlation between VEGF-C and MMP-2 gene expression levels (P < 0.05).
CONCLUSION: Tumor cells that produce VEGF-C may have a higher invasive and metastatic potential because of their capacity to pass through tissue barriers. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11426979     DOI: 10.1006/gyno.2001.6229

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  14 in total

1.  Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer.

Authors:  M Branca; C Giorgi; D Santini; L Di Bonito; M Ciotti; A Benedetto; P Paba; S Costa; D Bonifacio; P Di Bonito; L Accardi; C Favalli; K Syrjänen
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

2.  Blockade of MMP-2 and MMP-9 inhibits corneal lymphangiogenesis.

Authors:  Hai-Tao Du; Ling-Ling Du; Xian-Ling Tang; Hong-Yan Ge; Ping Liu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-01       Impact factor: 3.117

3.  VEGFR3 inhibition chemosensitizes ovarian cancer stemlike cells through down-regulation of BRCA1 and BRCA2.

Authors:  Jaeyoung J Lim; Kun Yang; Barbie Taylor-Harding; W Ruprecht Wiedemeyer; Ronald J Buckanovich
Journal:  Neoplasia       Date:  2014-04       Impact factor: 5.715

Review 4.  Tumor angiogenesis and molecular target therapy in ovarian carcinomas.

Authors:  Masatsugu Ueda; Yoshito Terai; Koji Kanda; Masanori Kanemura; Mikio Takehara; Hikari Futakuchi; Hiroyuki Yamaguchi; Masayuki Yasuda; Koji Nishiyama; Minoru Ueki
Journal:  Hum Cell       Date:  2005-03       Impact factor: 4.174

Review 5.  Angiogenesis and ovarian cancer.

Authors:  César Gómez-Raposo; Marta Mendiola; Jorge Barriuso; Enrique Casado; David Hardisson; Andrés Redondo
Journal:  Clin Transl Oncol       Date:  2009-09       Impact factor: 3.405

6.  Effect of vascular endothelial growth factor on remodeling of C6 glioma tissue in vivo.

Authors:  Lijuan Yang; Zhixiong Lin; Qiang Huang; Jianhua Lin; Zhenbin Chen; Linying Zhou; Pengfei Zhang
Journal:  J Neurooncol       Date:  2010-08-26       Impact factor: 4.130

7.  Association of serum vascular endothelial growth factor-C and lymphatic vessel density with lymph node metastasis and prognosis of patients with gastric cancer.

Authors:  Tian-Bao Wang; Mei-Hai Deng; Wan-Shou Qiu; Wen-Guang Dong
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

8.  In vitro and in vivo evidence for lack of endovascular remodeling by third trimester trophoblasts.

Authors:  S Kalkunte; Z Lai; N Tewari; C Chichester; R Romero; J Padbury; S Sharma
Journal:  Placenta       Date:  2008-09-04       Impact factor: 3.481

9.  VEGF Potentiates GD3-Mediated Immunosuppression by Human Ovarian Cancer Cells.

Authors:  Irina V Tiper; Sarah M Temkin; Sarah Spiegel; Simeon E Goldblum; Robert L Giuntoli; Mathias Oelke; Jonathan P Schneck; Tonya J Webb
Journal:  Clin Cancer Res       Date:  2016-04-13       Impact factor: 12.531

10.  VEGF-c expression in an in vivo model of orthotopic endometrial cancer and retroperitoneal lymph node metastasis.

Authors:  Yong-Wen Huang; Li-Qun Xu; Rong-Zhen Luo; Xin Huang; Teng Hou; Yan-Na Zhang
Journal:  Reprod Biol Endocrinol       Date:  2013-05-21       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.